Overview: Rational Design of 1α,25-Dihydroxyvitamin D3 Analogs (Deltanoids)

Vitamin D

Volumn 2, Issue , 2005, Pages 1405-1422

  Posner, Gary H ^a   Kahraman, Mehmet ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884879461     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012252687-9/50084-X     Document Type: Chapter

References (70)

1. Reichle H, Koeffler HP, Norman AW The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989, 320:980-991.
2. Vieth R The mechanisms of vitamin D toxicity. Bone Miner 1990, 11:267-272.
3. Bouillon R, Okamura WH, Norman AW Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995, 16:200-257.
4. Jones G, Strugnell SA, DeLuca HF Current understanding of the molecular actions of vitamin D. Physiol Rev 1998, 78:1193-1231.
5. Barger-Lux MJ, Heaney RP, Lanspa SJ, Healy JC, DeLuca HF An investigation of sources of variation, in calcium absorption efficiency. J Clin Endocrinol Metab 1995, 80:406-411.
6. Rasmussen H, Wong M, Bikle D, Goodman DBP Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest 1972, 51:2502-2504.
7. 2 as therapeutic agents for prostate cancer. Clin Cancer Res 2000, 6:901-908.
8. Crocker JS, Muhtadie SF, Hamilton DC, Cole DE The comparative toxicity of vitamin D metabolites in the weanling mouse. Biol Appl Pharmacol 1985, 80:119-126.
9. 2 on calcium homeostasis in postmenopausal osteopenic women. J Bone Miner Res 1994, 9:607-614.
10. 2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia. Am J Kidney Dis 1995, 26:852-860.
11. 5. J Natl Cancer Inst 1997, 89:212-218.
12. 3. J Steroid Biochem Mol Biol. 2004, 89-90:5-12.
13. 3 in kidney: Influence of structural modification of D-ring on side chain metabolism. Bioorg Med Chem Lett 1993, 3:1879-1884.
14. 3 analogs of calcitriol 2. Preliminary biological evaluation. Bioorg Med Chem Lett 1993, 3:1835-1840.
15. Peleg S, Uskokovic M, Ahene A, Vickery B, Avnur Z Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats. Endocrin 2002, 143:1625-1636.
16. Hansen CM, Hamberg KJ, Binderup E, Binderup L Seocalcitol (EB 1089): A vitamin D analog of anticancer potential. Background, design, synthesis, preclinical, and clinical evaluation. Curr Pharm Design 2000, 6:803-828.
17. Smith MB, March J Advanced Organic Chemistry 2001, Chapter 1, Wiley-Interscience, New York, NY. Fifth Edition.
18. Organofluorine Chemistry: Principles and Commercial Applications 1994, Plenum Press, New York. R.E. Banks, B.E. Smart, J.C. Tatlow (Eds.).
19. 3. Am J Physiol 1983, 244:E159-E163.
20. 3. J Med Chem 1990, 33:480-490.
21. 3. Synthesis and preliminary biological evaluation. J Med Chem 1998, 41:3008-3014.
22. Kensler TW, Dolan PM, Gange SJ, Lee J-K, Wang Q, Posner GH Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis. Carcinogen 2000, 21:1341-1345.
23. 3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells. J Steroid Biochem Mol Biol 1996, 59:405-412.
24. 3, is a potent suppressor of parathyroid, hormone secretion. J Cell Biochem 1999, 73:106-113.
25. Peleg S, Posner GH Vitamin D analogs as modulators of vitamin D receptor action. Curr Trends Med Chem 2003, 3:1555-1572.
26. Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Molecular Cell 2000, 5:173-179.
27. Tocchini-Valentini G, Rochel N, Wurtz JM, Mitschler A, Moras D Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci USA 2001, 98:5491-5496.
28. Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol 2002, 9:131-136.
29. Choi M, Yamamoto K, Masuno H, Nakashima K, Taga T, Yamada S Ligand recognition by the vitamin D receptor. Bioorg Med Chem 2001, 9:1721-1730.
30. Zhou X, Zhu G-D, Van Haver D, Vandewalle M, De Clercq PJ, Verstuyf A, Bouillon R Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1α,25-dihydroxyvitamin D analogs, diastereomeric at C17 and C20. J Med Chem 1999, 42:3539-3556.
31. 3 analogs. Bioorg Med Chem Lett 2002, 12:1629-1632.
32. Verstuyf A, Verlinden L, Van Baelen H, Sabbe K, D'Hallewyn C, De Clercq P, Vandewalle M, Bouillon R The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings. J Bone Miner Res 1998, 13:549-558.
33. Bauer FW, Barbier P, Mohr P, Phister T, Pirson W, Theil F-P Preclinical profile of the cyclohexanediol Ro 65-2299, a potential oral antipsoriatic. Vitamin D Endocrine System: Structural, Biological. Genetic, and Clinical Aspects 2000, 615-618. Printing and Reprographics, University of California, Riverside. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
34. 3 analogs, which selectively restore activity to a vitamin D receptor mutant associated with rickets. Org Lett 2002, 4:3863-3866.
35. Swann SL, Bergh J, Farach-Carson MC, Ocasio CA, Koh JT Structure-based design of selective agonists for a rickets-associated mutant of the vitamin D receptor. J Am Chem Soc 2002, 124:13795-13805.
36. 3. J Med Chem 2002, 45:1825-1834.
37. Yamada S, Yamamoto K, Masuno H, Ohta M Conformation function relationship of vitamin D: Conformational analysis predicts potential side-chain structure. J Med Chem 1998, 41:1467-1475.
38. Yamada S, Yamamoto K, Masuno H Structure function analysis of vitamin D and VDR model. Curr Pharm Des 2000, 6:733-748.
39. 3 with biased side-chain orientation: Methylated des-C, D-homo analogs. Chem Eur J 2001, 7:520-532.
40. Okamura WH, Palenzuela JA, Plumet J, Midland MM Vitamin D: Structure function analyses and the design of analogs. J Cell Biochem 1992, 49:1-9.
41. 3. J Med Chem 1991, 34:2452-2463.
42. 3: Synthesis and preliminary biological evaluation. J Med Chem 1999, 42:3425-3435.
43. Unpublished results of Drs. H. Masuno and S. Yamada, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan. We thank Drs. Masuno and Yamada for these docking data.
44. Ostrem VK, Lau WF, Lee SH, Perlman K, Prahl J, Schnoes HK, DeLuca HF Induction of monocytic differentiation of HL-60 cells by 1,25-dihydroxyvitamin D analogs. J Biol Chem 1987, 262:14164-14171.
45. Shimizu M, Iwasaki Y, Ohno A, Yamada S Synthesis of fluorovitamin D analogs for conformational analysis of ligand bound to vitamin D receptor. Vitamin D: Chemistry, Biology, and Clinical Applications of the Steroid Hormone: Proceedings from the Tenth Workshop on Vitamin D 1997, 24-25. Printing and Reprographics, University of California, Riverside. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
46. 3: Analog to probe A-ring conformation in vitamin D-receptor complex. Tett Lett 1999, 40:1697-1700.
47. Shimizu M, Ohno A, Iwasaki Y, Yamada S, Ooizumi H, DeLuca HF A-ring conformation and biological activity: Based on studies of fluorovitamin D analogs. Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects: Proceedings from the Eleventh Workshop on Vitamin D 2000, 45-48. Printing and Reprographics, University of California, Riverside. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
48. Okamura WH, Do S, Kim H, Jeganathan S, Vu T, Zhu G-D, Norman AW Conformationally-restricted mimics of vitamin D rotamers. Steroids 2001, 66:239-247.
49. 3. Org Lett 2002, 4:851-854.
50. 3. Steroids 2002, 67:457-466.
51. 2 (calciferol). J Org Chem 1986, 51:4819-4828.
52. 3 analogs. Chem Pharm Bull 1992, 40:1494-1499.
53. 3: Synthesis and biological evaluation. J Med Chem 2000, 43:3581-3586.
54. Dai H, Posner GH Synthetic approaches to vitamin D. Synthesis 1994, 1383-1398.
55. 3 compounds of high biological activity: Synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl and 2-methylene analogs. J Med Chem 1998, 41:4662-4674.
56. 3 selectively induces bone formation. Biochem 2002, 99:13487-13491.
57. Zhu G, Okamura WH Synthesis of vitamin D (calciferol). Chem Rev 1994, 95:1877-1952.
58. 3 library in the solid-phase. J Am Chem Soc. 2001, 123:3716-3722.
59. 3 analogs and their A-ring epimers. Eur J Org Chem 2001, 3779-3788.
60. 3 inhibit the growth of human breast cancer cells in vitro and in vivo. Cancer Res 2000, 60:2673-2679.
61. Kabat MM, Radinov R The practical synthesis of vitamin D analogs: A challenge for process research. Curr Opin Drug Discovery Dev 2001, 4:808-833.
62. Kabat MM, Garofalo LM, Daniewski AR, Hutchings SD, Liu W, Okabe M, Radinov R, Zhou Y Efficient synthesis of 1α-fluoro A-ring phosphine oxide, a useful building block for vitamin D analogs, from ( S)-carvone via a highly selective palladium-catalyzed isomerization of dieneoxide to dieneol. J Org Chem 2001, 66:6141-6150.
63. 3 and its 20-epi analogs. J Org Chem 2003, 68:1367-1375.
64. Uskokovic MR, Studzinski GP, Gardner JP, Reddy GS, Campbell MJ, Koeffler HP The 16-ene vitamin D analogs. Curr Pharm Des 1997, 3:99-123.
65. 3 side-chain units. Tett Lett 2002, 43:5009-5012.
66. 3: Synthesis and biological testing. J Med Chem 2002, 45:1723-1730.
67. Trost BM, Dumas J, Villa M New strategies for the synthesis of vitamin D metabolites via Pd-catalyzed reactions. J Am Chem Soc 1992, 114:9836-9845.
68. 3: Remarkably high affinity to vitamin D receptor. Org Lett 2000, 2:2619-2622.
69. 2-2: Calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring sterochemistry, Steroids 2004, submitted.
70. Unpublished results of Drs. H. Masuno and S. Yamada, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan. We thank Drs. Masuno and Yamada for these docking data.